about
Endocytotic potential governs magnetic particle loading in dividing neural cells: studying modes of particle inheritanceRobust uptake of magnetic nanoparticles (MNPs) by central nervous system (CNS) microglia: implications for particle uptake in mixed neural cell populationsHow do corticosteroids influence myelin genesis in the central nervous system?Remyelination in multiple sclerosis.New insights into remyelination failure in multiple sclerosis: implications for glial cell transplantation.Identifying the cellular targets of drug action in the central nervous system following corticosteroid therapy.Nanoengineering neural stem cells on biomimetic substrates using magnetofection technology.A fusion of minicircle DNA and nanoparticle delivery technologies facilitates therapeutic genetic engineering of autologous canine olfactory mucosal cells.Magnetic Nanoparticle-Mediated Gene Delivery to Two- and Three-Dimensional Neural Stem Cell Cultures: Magnet-Assisted Transfection and Multifection Approaches to Enhance Outcomes.Part II: Functional delivery of a neurotherapeutic gene to neural stem cells using minicircle DNA and nanoparticles: Translational advantages for regenerative neurology.Part I: Minicircle vector technology limits DNA size restrictions on ex vivo gene delivery using nanoparticle vectors: Overcoming a translational barrier in neural stem cell therapy.Modelling large areas of demyelination in the rat reveals the potential and possible limitations of transplanted glial cells for remyelination in the CNS.Dysfunctional oligodendrocyte progenitor cell (OPC) populations may inhibit repopulation of OPC depleted tissue.Alignment of multiple glial cell populations in 3D nanofiber scaffolds: toward the development of multicellular implantable scaffolds for repair of neural injury.Corticosteroids delay remyelination of experimental demyelination in the rodent central nervous system.A proteomic investigation into mechanisms underpinning corticosteroid effects on neural stem cells.'Stealth' nanoparticles evade neural immune cells but also evade major brain cell populations: Implications for PEG-based neurotherapeutics.Increasing magnetite contents of polymeric magnetic particles dramatically improves labeling of neural stem cell transplant populations.Development of Multifunctional Magnetic Nanoparticles for Genetic Engineering and Tracking of Neural Stem Cells.A multicellular, neuro-mimetic model to study nanoparticle uptake in cells of the central nervous system.Fe3O4-PEI-RITC magnetic nanoparticles with imaging and gene transfer capability: development of a tool for neural cell transplantation therapies.The transfection of multipotent neural precursor/stem cell transplant populations with magnetic nanoparticles.Magnetic nanoparticle labeling of astrocytes derived for neural transplantation.Development of a nanomaterial bio-screening platform for neurological applications.An in vitro spinal cord injury model to screen neuroregenerative materials.Efficient recolonisation of progenitor-depleted areas of the CNS by adult oligodendrocyte progenitor cellsDecline in rate of colonization of oligodendrocyte progenitor cell (OPC)-depleted tissue by adult OPCs with ageOligodendrocyte progenitor cell (OPC) transplantation is unlikely to offer a means of preventing X-irradiation induced damage in the CNSUptake of systemically administered magnetic nanoparticles (MNPs) in areas of experimental spinal cord injury (SCI)Enhancement of magnetic nanoparticle-mediated gene transfer to astrocytes by 'magnetofection': effects of static and oscillating fieldsNoninvasive imaging of nanoparticle-labeled transplant populations within polymer matrices for neural cell therapyNanoparticle-Based Imaging of Clinical Transplant Populations Encapsulated in Protective Polymer Matrices
P50
Q30773169-9194BFEC-7BA9-4313-BEA9-E9A524F25656Q33848133-602F6DA0-6829-4BB9-BC34-79EEA8DBAD2DQ34095959-B2133704-D607-460F-983A-42BEB8DEE2E3Q34632031-13871DBD-8628-4098-B6D6-7477A482E365Q34776128-9F34A2E6-B6EC-4412-A3B8-871768148403Q37489879-40A81303-086D-4318-ACEC-0A8F2514A696Q39314365-E6FE60CB-5DE9-4898-82FF-2AFE7AC315D9Q40160514-6D6384FF-9FC9-455D-8955-0259B06D25FEQ40353791-FF8312FD-F99E-47FC-BEE5-701836F566DCQ40670949-01E1058F-A160-4EE4-8DBB-476A2FE01607Q40694202-19E8861D-E31B-4080-9E83-945100F0C883Q43956388-75C9A354-F8FF-4158-8C39-E9AFE6B7333EQ44569656-59AFE26E-9A1E-49F9-8C1E-77D39E1D3A71Q44664063-50685E61-70DB-456D-BC81-A485E5D02C8FQ46906003-BA34677E-CA1D-480E-B6C2-E454E11C6585Q47413674-59535068-F33A-483A-B8C0-EFBB642DC6B6Q47887862-D092B2B7-919E-4B8C-B02E-09EFF49AC134Q48251691-747C9E50-E1C4-4019-9B74-FAA76F031E30Q48628755-9AE6F814-453B-4067-8AAD-BF8F82A0A02BQ50453168-669D8A34-BB51-4462-A5F2-AEE91B737084Q50668795-43494411-8FEC-4D37-AD59-39832D4E9235Q50690090-46111C14-521A-4C2E-8F61-3C136CC7D154Q50697499-F78A9DE3-A630-4295-8CFF-862CD5FE0448Q53478997-9EC65CCE-10B9-4588-8684-889823BB1466Q53628426-54F2415F-D3B1-465C-8A1D-24FA689C2FF4Q77707852-E52CAF9E-C62C-474C-A5E4-745E519207D2Q79132686-718D8506-5FD0-483D-8903-EAC13FF78563Q82250545-EB4FC7C4-E008-41BD-B6D9-3E2CBE2E4A36Q82811705-F8E4629F-0CD9-4002-A50C-063353C2277DQ82864751-5899705C-F313-4AAF-9B44-4B167A195250Q89289978-45236A67-AFF9-4109-8CC1-AF6A86232AB3Q90240436-3C5427C8-6DD5-4923-873B-3CFD69581BBC
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Divya M Chari
@ast
Divya M Chari
@en
Divya M Chari
@es
Divya M Chari
@nl
type
label
Divya M Chari
@ast
Divya M Chari
@en
Divya M Chari
@es
Divya M Chari
@nl
prefLabel
Divya M Chari
@ast
Divya M Chari
@en
Divya M Chari
@es
Divya M Chari
@nl
P106
P1153
6603165609
P31
P496
0000-0002-7095-8578